Acura Pharmaceuticals Soars After Launch of New Cold Medicine
December 10, 2012 at 15:21 PM EST
A press release on Monday morning has sent shares of Acura Pharmaceuticals (NASDAQ: ACUR ) sharply higher during the trading session. At last check, the stock had added around 64 percent and was trading at $2.36. The company announced the release of a "next generation pseudoephedrine product" which combines
